VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
LYRALyra Therapeutics, Inc.
$0.44$781126
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksLYRAPrice History

LYRA logoLyra Therapeutics, Inc. (LYRA) Stock Price History

Historical prices from 2020 to 2026

$0.44-0.05  (-11.09%)close Mar 18
Returns
1M
—
3M
+0.0%
YTD
-86.1%
1Y
-95.9%
3Y
-86.6%
5Y
-74.8%
ATH$1,100.00May 2020-100.0%
ATL$0.44Mar 2026pre-split
Avg Vol (50D)78K/ day
52-Week Range$0.44 — $14.88
LowCurrent: $0.44High

Loading 10-year price history...

LYRA Historical Performance

1 YearTotal Return
-95.9%
Price: -95.9%
3 YearsTotal Return
-99.8%
CAGR: -86.6%
Price: -99.8%
5 YearsTotal Return
-99.9%
CAGR: -74.8%
Price: -99.9%
YTD
-86.1%

LYRA Annual Returns

Year-by-year price performance · 2020–2026

Best+69.6%2023
Worst-96.0%2024
Up years1/7
2020-38.6%
2021-61.2%
2022-32.9%
2023+69.6%
2024-96.0%
2025-71.5%
2026-68.0%
2020 annual price return
-38.6%
2021 annual price return
-61.2%
2022 annual price return
-32.9%
2023 annual price return
+69.6%
2024 annual price return
-96.0%
2025 annual price return
-71.5%
2026 annual price return
-68.0%
LessMore
Alpha vs S&P 500
1Y-120.9%
3Y-106.2%
5Y-87.5%

Price returns only.

Download Historical Data

1,477 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

LYRA Stock Price Trajectory (2020–2026)

As of June 23, 2026, Lyra Therapeutics, Inc. (LYRA) trades at $0.44, representing a -95.9% return over the past year. The stock has delivered a -99.9% total return over five years (-74.8% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $1,100.00 on May 1, 2020. From this peak, LYRA has corrected -100.0%, currently trading 93% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers XNCR (+51.2% 1Y), PRAX (+557.0% 1Y), and SINT (-36.1% 1Y), LYRA has underperformed the peer group average. Compare LYRA vs XNCR →

LYRA Historical Price Data · from 2020

Rows 1–50 of 1,477
Date Open High Low Close Volume Change %
2026-03-180.460.480.440.4478K-11.09%
2026-03-161.291.330.490.491.02M-62.50%
2026-03-131.321.341.311.323K-1.49%
2026-03-121.321.351.321.348K+2.29%
2026-03-111.311.421.271.3116K+0.77%
2026-03-101.281.321.241.3013K0.00%
2026-03-091.281.301.281.309K+4.00%
2026-03-061.281.301.251.2515K-3.10%
2026-03-051.281.301.211.2920K+2.38%
2026-03-041.251.351.231.2647K+1.61%
2026-03-031.181.271.081.2483K+4.20%
2026-03-020.971.450.911.19703K+17.82%
2026-02-271.131.191.001.0183K-9.82%
2026-02-261.371.461.121.12124K-20.00%
2026-02-251.461.481.401.406K-4.11%
2026-02-241.441.471.391.4623K+0.69%
2026-02-231.461.461.431.455K0.00%
2026-02-201.501.501.451.451-2.68%
2026-02-191.411.521.411.4911K+6.43%
2026-02-181.391.471.391.4017K+5.97%
2026-02-171.451.471.311.328K-4.96%
2026-02-131.351.451.211.3981K+5.30%
2026-02-121.391.401.321.3229K-3.65%
2026-02-111.491.491.321.3740K-6.80%
2026-02-101.541.581.471.4724K-3.29%
2026-02-091.831.831.511.52100K-16.48%
2026-02-061.711.901.711.8221K+2.82%
2026-02-051.881.951.771.7716K-6.10%
2026-02-042.002.031.821.8923K-4.80%
2026-02-032.032.051.931.9812K-1.98%
2026-02-021.862.041.732.0290K+13.48%
2026-01-301.992.021.781.7827K-12.75%
2026-01-292.042.051.862.0473K-0.49%
2026-01-281.672.151.602.05186K+20.94%
2026-01-271.761.801.651.7058K-2.59%
2026-01-262.072.121.741.7480K-15.12%
2026-01-242.312.311.802.0556K0.00%
2026-01-232.242.311.802.0589K-6.82%
2026-01-222.292.392.182.2043K-2.22%
2026-01-212.412.442.202.2561K-3.85%
2026-01-201.972.581.942.34338K+17.59%
2026-01-161.992.021.891.9942K+2.31%
2026-01-151.891.971.891.9532K+2.91%
2026-01-141.951.971.851.8932K-5.03%
2026-01-131.962.061.781.99248K-3.40%
2026-01-122.002.271.632.061.39M-45.31%
2026-01-093.733.943.733.7714K-0.87%
2026-01-083.623.803.533.807K+5.26%
2026-01-073.353.623.343.6123K+7.44%
2026-01-063.383.463.293.3615K-0.59%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

LYRA — Frequently Asked Questions

Quick answers to the most common questions about buying LYRA stock.

How has LYRA stock performed recently?

LYRA declined -95.9% over the past year, below its 5-year annualized CAGR of -74.8%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is LYRA's all-time high price?

Lyra Therapeutics, Inc. reached $1100.00 on 2020-05-01. The 52-week high is $14.88. Current 1-year return of -95.9% places the stock further from historical peaks.

Where can I download LYRA historical price data?

This page provides LYRA daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2020-2026, downloadable in CSV format.

493 data points · sampled from 1,477